Open Access

Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)

  • Authors:
    • Stella Baliou
    • Anthony M. Kyriakopoulos
    • Demetrios  A. Spandidos
    • Vassilios Zoumpourlis
  • View Affiliations

  • Published online on: July 14, 2020     https://doi.org/10.3892/ijo.2020.5100
  • Pages: 631-664
  • Copyright: © Baliou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

For one century, taurine is considered as an end product of sulfur metabolism. In this review, we discuss the beneficial effect of taurine, its haloamines and taurine upregulated gene 1 (TUG1) long non‑coding RNA (lncRNA) in both cancer and inflammation. We outline how taurine or its haloamines (N‑Bromotaurine or N‑Chlorotaurine) can induce robust and efficient responses against inflammatory diseases, providing insight into their molecular mechanisms. We also provide information about the use of taurine as a therapeutic approach to cancer. Taurine can be combined with other chemotherapeutic drugs, not only mediating durable responses in various malignancies, but also circumventing the limitations met from chemotherapeutic drugs, thus improving the therapeutic outcome. Interestingly, the lncRNA TUG1 is regarded as a promising therapeutic approach, which can overcome acquired resistance of cancer cells to selected strategies. In this regard, we can translate basic knowledge about taurine and its TUG1 lncRNA into potential therapeutic options directed against specific oncogenic signaling targets, thereby bridging the gap between bench and bedside.
View Figures
View References

Related Articles

Journal Cover

September-2020
Volume 57 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Baliou S, Kyriakopoulos AM, Spandidos DA and Zoumpourlis V: Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review). Int J Oncol 57: 631-664, 2020
APA
Baliou, S., Kyriakopoulos, A.M., Spandidos, D.A., & Zoumpourlis, V. (2020). Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review). International Journal of Oncology, 57, 631-664. https://doi.org/10.3892/ijo.2020.5100
MLA
Baliou, S., Kyriakopoulos, A. M., Spandidos, D. A., Zoumpourlis, V."Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)". International Journal of Oncology 57.3 (2020): 631-664.
Chicago
Baliou, S., Kyriakopoulos, A. M., Spandidos, D. A., Zoumpourlis, V."Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)". International Journal of Oncology 57, no. 3 (2020): 631-664. https://doi.org/10.3892/ijo.2020.5100